GlassScriptPhysician profile
Mena Yacoub
NPI 1003223835
$52,118.77
in general payments reported to CMS, 2019-2025
22 companies · $7,099 in 2025
The $7,099 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $350 · 2021: $15K · 2022: $12K · 2023: $12K · 2024: $4,478 · 2025: $7,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $6,358 · Consulting Fee: $3,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,417.84 |
| Travel and Lodging | $6,357.97 |
| Consulting Fee | $3,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $23,630.68 | 2021-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Sentus |
| Abbott Laboratories | $7,819.67 | 2022-2025 | Accent, Aveir, Gallant |
| Medtronic, INC. | $7,775.87 | 2021-2025 | Linq II, Selectsecure, Mycarelink |
| Boston Scientific Corporation | $4,837.04 | 2019-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Biosense Webster, INC. | $3,367.73 | 2023-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Cvrx, INC. | $1,084.80 | 2022-2025 | Barostim Neo System |
| Medical Device Business Services, INC. | $973.03 | 2023 | Carto 3 |
| Cardiva Medical, INC. | $544.38 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Stereotaxis INC | $384.88 | 2022 | |
| Philips North America LLC | $367.56 | 2023-2025 | (Am5) Lead Management, Mechanical Tools |
| Medtronic Vascular, INC. | $294.20 | 2019 | |
| Kestra Medical Technology Services, INC. | $232.11 | 2023-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $177.86 | 2019 | |
| Atricure, INC. | $176.37 | 2023 | |
| Edwards Lifesciences Corporation | $124.99 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $100.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.64 | 2022 | |
| Merck Sharp & Dohme LLC | $47.58 | 2024 | Bridion |
| Amgen INC. | $37.80 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.41 | 2024 | |
| Pfizer INC. | $15.37 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.80 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mena Yacoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.